| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5597644 | The Annals of Thoracic Surgery | 2016 | 6 Pages |
Abstract
Using invasive mediastinal staging to exclude N2 disease has a role in surgical decision making and achieving long-term survival among oligometastatic NSCLC patients. Further study is warranted to determine whether a subset of patients with N2 disease also have the potential for long-term survival with local therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Katelyn K. BA, Joshua E. BASc, Michelle C. MD, Daniel J. MD,